Determination of lymph node micrometastases in patients with supraglottic carcinoma

Acta Oto-Laryngologica

Volumn 127, Issue 11, 2007, Pages 1188-1195

  Xu, Yaping ^a   Zhao, Xuequn ^a   Guan, Ming ^a   Li, Binghua ^b   Zhou, Yan ^a   Zhou, Fang ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Zhejiang People's Provincial Hospital   (China)

Author keywords

Cervical lymph node; Cytokeratin; Head and neck cancer; Larynx cancer; Loss of heterozygosity; Metastasis; Occult metastasis

Indexed keywords

CYTOKERATIN 19; EOSIN; HEMATOXYLIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MALE; MICROMETASTASIS; NECK DISSECTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; FEMALE; GLOTTIS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-19; LARYNGEAL NEOPLASMS; LOSS OF HETEROZYGOSITY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK; POLYMERASE CHAIN REACTION; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 35348999059     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480701200327     Document Type: Article

References (22)

1. Marchant FE, Lowry LD, Moffit JJ, Sabbagh R. Current trends in posttreatment follow-up of patients with squamous cell carcinoma of the head and neck. Am J Otolaryngol 1993;14:88-93.
2. Braams JW, Pruim J, Freling NJ, Nikkeles PG, Roodenberg JL, Boering G, et al. Detection of lymph node metastases of squamous cell cancer of head and neck with FDG-PET and MRI. J Nucl Med 1995;36:211-6.
3. Lee KN, Gorepfert H, Wendt CD. Supraglottic laryngectomy for intermediate stage cancer. UT MD Anderson cancer center experience with combined therapy. Laryngoscope 1990;100:831-6.
4. Dursun G, Keser R, Akturk T, Akiner MN, Demireller A, Sak SD. The significance of preepiglottic space invasion in supraglottic laryngeal carcinomas. Eur Arch Otorhinolaryngol 1997;254(Suppl 1):S110-S112.
5. Scola B, Fernandez-Vega M, Martinez T, Fernandez-Vega S, Ramrez CL. Management of cancer of the supraglottis. Otolaryngol Head Neck Surg 2001;124:195-9.
6. Ambrosch P, Kron M, Fisher G, Brinck U. Micrometastases in carcinoma of upper aerodigestive tract: detection, risk of metastasizing, the prognostic value of depth of invasion. Head Neck 1995;17:473-9.
7. El-Naggar AK, Hurr K, Luna MA, Goepfert H, Hong WK, Batsakis JG. Intratumoral genetic heterogeneity in primary head and neck squamous cell carcinoma using microsatellite marker. Diagn Mol Pathol 1997;6:305-8.
8. Nawroz H, van Der Riet P, Hruban RH, Koch W, Ruppert JM, Sidransky D. Allelotype of head and neck squamous carcinoma. Cancer Res 1994;54:1152-5.
9. Uzawa K, Suzuki H, Komoya A, Nakanishi H, Ogawara K, Tanzawa H, et al. Evidence for two distinct tumor-suppressor gene loci on the long arm of chromosome 11 in human oral cancer. Int J Cancer 1996;67:510-4.
10. Kwon SY, Kim HJ, Woo JS, Jung KY, Kim I. The usefulness of cytokeratin immunohistochemistry in detection of lymph node micrometastasis in neck dissection specimens. Otolaryngol Head Neck Surg 2004;131:300-6.
11. Ferlito A, Devaney KO, Debvaney SL, Rinaldo A. What is the incidence of occult metastasis in patients with stage N(0) cancers of the head and neck? ORL J Otorhinolaryngol Relat Spec 2001;63:1-5.
12. Lindemamn F, Schlimok G, Dirschedl P, Witte J, Riethmuller G. Prognostic significance of micrometastatic tumor cells in bone marrow of colorectal cancer patients. Lancet 1992;340:685-9.
13. Wang HY, Sun JM, Lu HF, Shi DR, Ou ZL, Ren YL, et al. Micrometastases detected by cytokeratin 19 expression in sentinel lymph nodes of patients with early-stage cervical cancer. Int J Gynecol Cancer 2006;16:643-8.
14. Wu ZY, Li JH, Zhan WH, He YL. Lymph node micrometastasis and its correlation with MMP-2 expression in gastric carcinoma. World J Gastroenterol 2006;12:2941-4.
15. Marx J. New colon cancer gene discovered. Science 1993;260:751-2.
16. Yamamoto N, Mizoe JE, Numasawa H, Yokoe H, Uzawa K, Shibahara T, et al. Allelic loss of chromosome 2 in human oral squamous cell carcinoma: correlation with lymph node metastasis. Oral Oncol 2003;39:64-8.
17. Van der Riet P, Nawroz H, Hruban RH, Corio R, Tokino K, Koch W, et al. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy. Cancer Res 1994;54:1156-8.
18. Li Z, Huang X, Li J. A study of human breast carcinoma xenografts in nude mice. Zhonghua Yi Xue Za Zhi 2000;80:865-8.
19. Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997;226:271-6.
20. Pajonk F, Schlessmann S, Guttenburger R, Henke M. Epithelia cells in the peripheral blood of patients with cancer of the head and neck: incidence, detection and possible clinical significance. Radiother Oncol 2001;59:213-7.
21. Rogowski M, Walenczak I, Pepinski W, Skawronska M, Sieskiewicz A, Klatka J. Loss of heterozygosity in laryngeal cancer. Rozc Akad Med Bialymst 2004;49:262-4.
22. Szukala K, Sowinska A, Wierzbicka M, Biczysko W, Szyfter W, Szyfier K. Does loss of heterozygosity in critical genome regions predict a local relapse in patients after laryngectomy? Mutat Res 2006;30:67-76.